Inventor

HROPOT MAX

DE17 patents

⚠️ This page may combine multiple inventors who share the name “HROPOT MAX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HROPOT MAX

HOECHST AG

Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

2-aminomethyl-6-sulfamoylphenol derivatives, a process for their preparation and their use and also pharmaceutical formulations based on these compounds

5-(4-Chloro-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylic acids and their compositions having diuretic, saluretic and uricosuric activity

Use of amino-substituted benzoic acids as remedies for diarrhea, and medicaments based on these compounds

Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them

Peptides influencing diuresis and natriuresis, a process for their preparation, agents containing them, and their use

Hirudin derivatives and a process for their preparation

Benzenesulfonamide derivatives and a process for the preparation thereof

Benzenesulfonamide derivatives and a process for the medical use thereof

2-Aminomethyl-6-sulfamoylphenol derivatives with salidiuretic activities

Benzenesulfonamide derivatives and processes for their manufacture

5-Phenyltetrazoles and their use as salidiuretics

Base-substituted anthranilic acids, a process for their preparation and their use

Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders

N-substituted aminoalkanoic acids, a process for their preparation, their use and pharmaceutical products based on these compounds

AVENTIS PHARMA GMBH

Substituted cinnamic, acid guanidides, process for their preparation, their use as a medicament, and medicament comprising them

MAX PLANCK GESELLSCHAFT

N-substituted 5-nitroanthranilic acids, a process for their preparation, their use, and pharmaceutical products based on these compounds